Homepage
Catalog of Screening Compounds
Screening Libraries
Focused and Target Libraries
Active Reference Sets
Diversity Libraries
Screening Compounds
Building blocks
Drug Discovery Services
Custom Chemistry
Medicinal chemistry
In silico Drug Design (CADD)
Discovery Biology
Animal Models
Toxicology and Safety
ADME, DMPK
Chemistry, Manufacturing and Controls
Company
News & Media
Contact us
For suppliers
Trends in discovery compounds
Homepage
>
Company
>
Media
>
Company news
>
2025
>
MSD wins FDA
MSD wins FDA
Read also
Gossamer Bio
Gossamer Bio to Present Clinical and Preclinical Data at the Pulmonary Vascular Research Institute 2025 Annual Congress
Amgen opens new drug substance
Amgen opens new drug substance facility in North Carolina, US
BIA report
BIA report: UK biotech investment surged to £3.5bn in 2024
SLAS 2025
We’re excited to announce that ChemDiv, Inc. will be attending SLAS 2025 in beautiful San Diego, January 25–29!
